These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 933715)

  • 1. Effect of acute and chronic injections of amphetamine on intracranial self-stimulation (ICS) and some aryl alkyl amines and the rat brain.
    Danielson TJ; Wishart TB; Boulton AA
    Life Sci; 1976 Jun; 18(11):1237-43. PubMed ID: 933715
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of acute and chronic injections of d-amphetamine sulfate and substantia nigra lesions on the distribution of amphetamine and para-hydroxyamphetamine in the rat brain.
    Danielson TJ; Petrali EH; Wishart TB
    Life Sci; 1976 Oct; 19(8):1265-9. PubMed ID: 994725
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary studies of the sodium borohydride stabilizable binding of phenylethylamine and tyramine to brain preparations.
    Ungar F; Mosnaim AD; Ungar B; Wolf ME
    Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):427-34. PubMed ID: 653100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of microinjections of amphetamine into the neostriatum and the nucleus accumbens on self-stimulation behaviour.
    Broekkamp CL; Pijnenburg AJ; Cools AR; Van Rossum JM
    Psychopharmacologia; 1975 May; 42(2):179-83. PubMed ID: 1161977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on hypothalamic self-stimulation of drugs influencing dopaminergic neurotransmission injected into nucleus accumbens and corpus striatum of rats.
    Stephens DN; Herberg LJ
    Psychopharmacology (Berl); 1977 Aug; 54(1):81-5. PubMed ID: 198840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar potency ratios of amphetamine optical isomers for inhibition of dopamine uptake by synaptosomes of corpus striatum, olfactory tubercle and prefrontal cortex of the rat.
    Matthews RT; Shore PA
    Biochem Pharmacol; 1984 Sep; 33(17):2817-9. PubMed ID: 6466390
    [No Abstract]   [Full Text] [Related]  

  • 7. The behavioral effects of D-amphetamine are correlated with its effects on cAMP in different brain regions.
    Kennedy LA; Zigmond MJ
    Brain Res; 1979 May; 168(2):408-13. PubMed ID: 221074
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional release of aromatic amines from tissues of the rat brain in vitro.
    Baldessarini RJ; Vogt M
    J Neurochem; 1972 Mar; 19(3):755-61. PubMed ID: 4555500
    [No Abstract]   [Full Text] [Related]  

  • 9. Melanin formation by human brain in vitro.
    Rodgers AD; Curzon G
    J Neurochem; 1975 Jun; 24(6):1123-9. PubMed ID: 1127428
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of D-amphetamine and antipsychotic drug administration on striatal tyramine levels in the mouse.
    Juorio AV
    Brain Res; 1977 Apr; 126(1):181-4. PubMed ID: 15705
    [No Abstract]   [Full Text] [Related]  

  • 11. Release of aromatic amines from brain tissues of the rat in vitro.
    Baldessarini RJ
    J Neurochem; 1971 Dec; 18(12):2509-18. PubMed ID: 4944458
    [No Abstract]   [Full Text] [Related]  

  • 12. The release of endogenous 3,4-dihydroxyphenethylamine from synaptosomes isolated from corpus striatum,
    De Belleroche JA; Bradford HF
    Biochem Soc Trans; 1975; 3(1):99-101. PubMed ID: 1126552
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release.
    Altar CA; Boyar WC; Oei E; Wood PL
    Brain Res; 1988 Sep; 460(1):76-82. PubMed ID: 3219572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Phenylethylamine and reinforcement.
    Greenshaw AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):615-20. PubMed ID: 6442439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncontingent displacement of catecholamines by intraventricular tyramine: biphasic dose-response effects on self-stimulation.
    Franklin KB; Herberg LJ
    Neuropharmacology; 1977 Jan; 16(1):53-5. PubMed ID: 834362
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of haloperidol and d-amphetamine on cerebral tyramine and octopamine levels.
    Juorio AV; Danielson TJ
    Eur J Pharmacol; 1978 Jul; 50(1):79-82. PubMed ID: 354941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor.
    Dyck LE
    Life Sci; 1989; 44(17):1149-56. PubMed ID: 2716465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic and noradrenergic substrates of positive reinforcement: differential effects of d- and l-amphetamine.
    Phillips AG; Fibiger HC
    Science; 1973 Feb; 179(4073):575-7. PubMed ID: 4686463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of tolerance or sensitization to the effects of chronic d-amphetamine on substantia nigra self-stimulation.
    Liebman JM; Segal DS
    Behav Biol; 1976 Feb; 16(2):211-20. PubMed ID: 176995
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of d-amphetamine, beta-phenylethylamine, cocaine and methylphenidate on the rate of dopamine synthesis in terminals of nigrostriatal and mesolimbic neurons and on the efflux of dopamine metabolites into cerebroventricular perfusates of rats.
    Nielsen JA; Chapin DS; Moore KE
    Life Sci; 1983 Nov; 33(19):1899-907. PubMed ID: 6645784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.